Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.biopharmadive.com/news/bms-karxt-schizophrenia-approval-abbvie/724555/
https://www.prnewswire.com/news-releases/abbvie-completes-acquisition-of-cerevel-therapeutics-302212336.html
https://www.biopharmadive.com/news/cerevel-parkinsons-tavapadon-study-results-abbvie/713566/
https://www.globenewswire.com/news-release/2024/04/18/2865216/0/en/Cerevel-Therapeutics-Announces-Positive-Topline-Results-for-Tavapadon-in-Phase-3-Adjunctive-Trial-for-People-Living-with-Parkinson-s-Disease.html
https://www.investorsobserver.com/news/stock-update/cerevel-therapeutics-holdings-inc-cere-is-lower-by-3-66-tuesday-in-premarket-trading
https://www.reuters.com/markets/deals/abbvie-buy-drug-developer-cerevel-87-billion-2023-12-06/
https://www.globenewswire.com//news-release/2023/11/29/2787576/0/en/Cerevel-Therapeutics-to-Host-Investor-Webcast-on-Tavapadon-in-Parkinson-s-Disease.html
https://investors.cerevel.com/news-releases/news-release-details/cerevel-therapeutics-present-evercore-isi-3rd-annual-healthconx
https://investors.cerevel.com/news-releases/news-release-details/cerevel-therapeutics-announces-third-quarter-2020-financial
https://www.globenewswire.com//news-release/2023/11/08/2775997/0/en/Cerevel-Therapeutics-to-Present-at-Upcoming-Investor-Conferences.html